Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Jun 02, 2023 | Option Exercise | $3.10 | 78,162 | 242,302 | 87,973 | Jun 02, 2023, 07:03 PM | |
RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Apr 05, 2023 | Sale | $56.06 | 20,000 | 1,121,200 | 19,811 | Apr 07, 2023, 09:02 PM | |
RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Mar 06, 2023 | Option Exercise | $62.91 | 20,000 | 1,258,300 | 19,811 | Mar 08, 2023, 09:33 PM | |
RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Feb 15, 2023 | Option Exercise | $61.54 | 10,000 | 615,400 | 14,811 | Feb 17, 2023, 09:34 PM | |
RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Jan 17, 2023 | Option Exercise | $61.35 | 10,000 | 613,500 | 14,811 | Jan 19, 2023, 08:42 PM | |
HSTO | Histogen Inc. | Marshall Keith W | EVP, COO & CFO | May 22, 2020 | Option Exercise | $0.56 | 18,615 | 10,424 | 19,885 | May 27, 2020, 06:09 AM |